Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
FKBP11 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
MIR1908 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CBS - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ERO1A - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
MIR3652 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CDK2AP2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SSR3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SCARNA15 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors
EIF2AK3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
LAX1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TLE3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
MEN1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GRB14 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
BLOC1S5-TXNDC5 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CAPRIN1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SPATA5L1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on